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Objective To assess differences in cytokine levels in cervicovaginal ﬂuid (CVF) and
serum across trimesters between women with preterm births (PTBs) and full-term
births.
Study Design This multicenter study enrolled 302 women with a singleton gestation.
CVF and serum cytokines, interleukin 1α (IL-1α), IL-1β, IL-6, IL-8, IL-10, C-reactive protein
(CRP), tumor necrosis factor (TNF)-α, and matrix metalloproteinase (MMP)-8, were
measured. Women with at least one cytokine assessment and noted PTB status in their
medical record were retained in the study (N ¼ 272). Data were analyzed using mixed
modeling (main effects of PTBs and time/trimester).
Results For the CVF values of IL-6, IL-8, IL-10, TNF-α, and CRP, and serum MMP-8, those
who delivered preterm had signiﬁcantly higher values than the full-term group
regardless of trimester. For the serum values of IL-1β, IL-6, and TNF-α, those delivering
preterm had signiﬁcantly lower values than those delivering full-term regardless of
trimester. For IL-1β in CVF, the cytokine was signiﬁcantly higher in the PTB group
for second and third trimesters only, relative to the full-term group.
Conclusion For each CVF cytokine that differed by birth status, values were higher for
PTB than term, averaged over trimester. Numerous cytokine proﬁles varied across
trimesters in women delivering term versus preterm in both CVF and serum.

While different cytokines are present in varying concentrations throughout the course of the pregnancy, a balance
ensures that the fetus is carried to term. The interleukins
(ILs) assessed in this study included IL-1α, IL-1β, IL-6, IL-8, and
IL-10, while other cytokines, such as tumor necrosis factor
(TNF)-α, C-reactive protein (CRP), and matrix metalloproteinase (MMP)-8, were also measured. While these cytokines
generally play differing roles in the human body, some altera-

tions may be an indicator for other adverse pregnancy outcomes, and all cytokines can have adverse effects during
pregnancy if their levels are abnormal. IL-1α and IL-1β peak
prior to labor onset,1 while IL-6, IL-8, and IL-10 are all
components of the inﬂammatory pathway that must be halted
to prevent fetal rejection.2–4 CRP is also involved in the
inﬂammatory process during pregnancy and maternal levels
can be associated with fetal growth restrictions and increased
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risk of neonatal complications.5 TNF-α is a multifunctional
cytokine, but its primary role during pregnancy is to terminate
development if the embryo has suffered damages that will
result in abnormal development.6 When this cytokine is
released inappropriately, the embryo can be terminated
even when lacking abnormalities.
Cytokine concentrations change throughout pregnancy.7
Many of those involved with the inﬂammatory process, including IL-1β and IL-8, decrease to protect the fetus during gestation.8 Other lipopolysaccharide-stimulated cytokines, such as
IL-6 and TNF-α, have shown a signiﬁcant increase across the
course of pregnancy.8 The mechanisms of these changes are
not well understood, but the phenomenon has been observed
in longitudinal studies.8,9 Cytokine levels during pregnancy
may be speciﬁcally linked to precursors to preterm birth. In
particular, the release of inﬂammatory cytokines, normally in
response to a bacterial infection, accounts for approximately
half of all preterm births.10,11 The objective of this study was to
assess whether there are differences in cytokine levels across
trimesters between women with preterm and full-term births,
controlling for maternal sociodemographic and personal factors. A secondary objective was to contrast ﬁndings between
cytokine levels obtained from cervicovaginal ﬂuid (CVF) and
those obtained from serum.

Materials and Methods
These data were obtained from a prospective, multicenter
trial of women with singleton pregnancies. The longitudinal
design assessed demographics and outcomes at each trimester of pregnancy. Potential participants were approached
and screened in the ﬁrst trimester of pregnancy. Exclusion
criteria targeted conditions with signiﬁcant inﬂuence on
immune markers including preexisting diabetes, heart disease, a medical history of human immunodeﬁciency virus
(HIV), bacterial vaginosis, sexually transmitted infections,
any autoimmune disease, or positive drug use. The study was
approved by the Institutional Review Boards at each data
collection site. Written consent was obtained from all participants, who were given modest compensation at each
trimester. Women who completed at least one cytokine
assessment were retained in the study (N ¼ 272). Of these,
there were 257, 234, and 219 with maternal serum measurements and 242, 217, and 194 with CVF measurements across
the three trimesters. Cytokines included: IL-1α, IL-1β, IL-6,
IL-8, IL-10, TNF-α, CRP, and MMP-8. Fewer CVF samples were
collected, as about 9% of women did not provide a specimen
due to a medical condition (e.g., vaginal bleeding, reports of
cramping or discomfort) or refusal. The numbers of samples
available for MMP-8 (serum: 185, 164, 150; and CVF: 165,
147, 124, respectively) are lower than other biomarkers, as it
was added at study midpoint. Trimester collection windows
ranged for 6 weeks (8–13, 18–23, and 28–33 weeks) with a
minimum of 4 weeks between collection periods.

Sample Collection and Cytokine Estimation
Clotted blood samples were centrifuged at 2,000 rpm for
10 minutes, and the serum was divided into three aliquots
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and stored at 80°C. Samples were analyzed undiluted. For CVF
specimens, samples were obtained after the speculum was
placed and the cervix visualized. An ectocervical sample was
collected by sweeping the cervix 360 degrees and kept in place
for 30 seconds to maximize saturation. When removing the
swab (source), a vaginal sample was obtained by sweeping
360 degrees in the vaginal vault/posterior fornix. The swab was
then placed in the proprietary container, ﬁrmly pressed against
the inner cryovial wall to ensure maximum seepage of ﬂuid
into the buffer container; and the vial cap was secured. All
serum and CVF specimens had sufﬁcient amount for analysis,
as high-sensitivity assays were used to detect below-minimum
concentrations. All samples were immediately refrigerated and
were transported to the laboratory within 6 hours, where they
were stored at 20°C for a minimum of 24 hours. To further
process, samples were thawed at 4°C and then centrifuged at
3,750 rpm for 15 minutes. For long-term storage, the samples
were split into three aliquots and stored at 80°C. Cytokines
IL-1α, IL-1β, IL-6, IL-8, IL-10, and TNF-α were measured using
multiplex Beadlyte assay (MPXHCYTO-60K-06) on a Luminex
IS-100 (Austin, TX) according to the manufacturer’s recommendations. High-sensitivity testing was used for samples
below minimum detectable concentrations. Singleplex assays
were used for CRP (Millipore, Billerica, MA) and MMP-8 (R&D
Systems, Minneapolis, MN). The dynamic range of the assays
was 50 to 0.016 ng/mL, with a minimum detection concentration of 0.0012 ng/mL. All cytokine data were generated using
Milliplex Analyst Software.

Statistical Analysis
Consistent with prior research,9 any CVF or serum cytokine
value classiﬁed as an outlier (i.e., outside of 3 SD from the mean)
was excluded from this analysis. The range in number of
excluded values for any given cytokine and trimester was 1
to 11; the average number of omitted values across the cytokines and trimesters was 4.4 (SD ¼ 1.8). Prior to analysis, all
cytokine values were log-transformed (natural logarithm) as an
adjustment for lack of normality in the raw values. Bivariate
analyses, including the two-sample t-test or chi-square test of
association, were used to compare demographic and personal
characteristics between women who experienced preterm
versus full-term births. Repeated-measures mixed modeling
was used to discern differences in cytokine levels by preterm
birth status during pregnancy, using the MIXED procedure in
SAS. This method was chosen as it allowed for the inclusion of
multiple cytokine values per participant (i.e., one for each
trimester they were assessed), and also permitted the inclusion
of women who did not have all three assessments in the
analysis, whether due to lack of sample, a measure outside
the 3 SD limit, or missed assessments due to preterm birth or
other reasons.
The primary comparison for each mixed model was
between length-of-pregnancy groups (i.e., women with preterm and full-term births). Other factors included in the
model were age, race/ethnicity, education, ﬁrst-trimester
smoking status, and trimester of pregnancy. We also
included the interaction between length-of-pregnancy
group and trimester in the initial models but removed the
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interaction in all but one model (CVF IL-1β) due to lack of
signiﬁcance of the trimester by group interaction in the full
model. This suggests that for all cytokines, with the exception
of IL-1β in CVF, the pattern of change over the three trimesters in average cytokine levels did not differ between the
two length-of-pregnancy groups. On the other hand, signiﬁcant main effects of length-of-pregnancy group or trimester
for some cytokines suggest that there are differences
between the two term groups (averaged over trimester) or
among the trimesters (averaged over term group). Post hoc
pairwise comparisons for signiﬁcant main or interaction
effects were accomplished using Fisher’s least signiﬁcant
difference procedure. All analysis was conducted using SAS v.
9.4; an α level of 0.05 was used throughout.

Results
Of the 272 women with at least one cytokine measurement
during at least one trimester who also had their length of
pregnancy recorded, 39 had preterm births and the remaining 233 participants had full-term births. No differences in
maternal age, body mass index, parity, race, education,
income, or smoking status were identiﬁed between those
who delivered preterm and term (see ►Table 1). Among
those who delivered preterm, the average gestational age at
delivery was 34.3 weeks (SD ¼ 2.7). The vast majority of
Table 1 Comparison of characteristics between length-ofpregnancy groups, including all women with at least one
cytokine level measured during pregnancy (N ¼ 272)
Preterm
(n ¼ 39)

Full-term
(n ¼ 233)

p

Maternal age,
mean (SD)

26.8 (6.4)

26.6 (5.1)

0.87a

Body mass index,
mean (SD)

26.6 (5.7)

26.5 (6.3)

0.98a

0

15 (44.1%)

123 (55.2%)

0.24

1

9 (26.5%)

47 (21.1%)

2 or more

10 (29.4%)

53 (23.8%)

White

28 (75.7%)

176 (75.9%)

Other

9 (24.3%)

56 (24.1%)

Less than high school

3 (7.9%)

33(14.2%)

High school or above

35 (92.1%)

199 (85.8%)

Less than $20,000

13 (35.1%)

63 (23.3%)

$20,000 or more

24 (64.9%)

160 (71.7%)

Parity, n (%)

Race, n (%)
0.98

Education, n (%)
0.29

Income, n (%)
0.39

First trimester smoking status, n (%)

a

Smoker

12 (31.6%)

54 (24.0%)

Nonsmoker

26 (68.4%)

171 (76.0%)

0.32

Group comparison via two-sample t-test; all other comparisons via
chi-square test of association.
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deliveries resulted from spontaneous preterm birth (n ¼ 26).
while others were a result of preterm premature rupture of
membranes (PPROM) or iatrogenic.

CVF Levels across Trimesters by Length-of-Pregnancy
Status
Repeated-measures models showed signiﬁcant main effects of
length-of-pregnancy status (i.e., preterm vs. term) averaged
over trimester for IL-6, IL-8, IL-10, TNF-α, and CRP
(see ►Table 2), controlling for maternal age, race, education,
and ﬁrst trimester smoking status. For each of the cytokines
with signiﬁcant length-of-pregnancy main effects, the CVF
cytokine levels were elevated in those who delivered preterm
compared with women with full-term pregnancies
(see ►Fig. 1). A signiﬁcant difference in the change of CVF
IL-1β levels was noted across pregnancy between women who
delivered preterm and term (i.e., signiﬁcant length-of-pregnancy by trimester interaction effect; see ►Fig. 2). Women
who delivered preterm had signiﬁcantly elevated levels at mid
and late trimester, compared with those who delivered fullterm; there was no difference in CVF IL-1β between the two
groups during early pregnancy (ﬁrst trimester). No differences
were detected in IL-1α or MMP-8 by preterm birth status, and
the interaction between trimester and length-of-pregnancy
was not signiﬁcant for these two cytokines.
The main effect of trimester, regardless of term status,
was signiﬁcant for the CVF measurements of IL-1α, IL-8, IL-10,
TNF-α, and MMP-8. With the exception of TNF-α, each of these
cytokines increased as pregnancy progressed. For TNF-α, the
level decreased during the course of pregnancy (see ►Fig. 3). For
IL-1α, IL-10, and MMP-8, ﬁrst-trimester measurements were
signiﬁcantly less than the measurements at both second and
third trimester, while for IL-8 the ﬁrst-trimester level was
signiﬁcantly less than only the third trimester. For TNF-α, the
level at ﬁrst trimester was signiﬁcantly greater than both second
and third trimesters, while second trimester values were also
signiﬁcantly greater than third.

Serum Levels across Trimesters by Length-ofPregnancy Status
Results from the adjusted linear mixed models based on the
serum values showed signiﬁcant main effects of preterm
birth status regardless of trimester for IL-1β, IL-6, TNF-α, and
MMP-8 (see ►Table 2). Serum levels of IL-6, IL-1β, and TNF-α
were signiﬁcantly lower for those who delivered preterm
relative to full-term deliveries, but MMP-8 was signiﬁcantly
higher (see ►Fig. 4). A difference in systemic levels of IL-1α,
IL-8, IL-10, or CRP was not observed by preterm birth status.
None of the eight cytokines measured exhibited a signiﬁcant
preterm status by trimester interaction.
The main effect of trimester, regardless of preterm/fullterm birth, was signiﬁcant for serum IL-8, TNF-α, and CRP,
but not for the other ﬁve cytokines assessed. For IL-8, the
level at second trimester was signiﬁcantly less than at third
trimester, but the ﬁrst trimester level did not differ signiﬁcantly from either of the later levels (see ►Fig. 5). For CRP and
TNF-α, an increase was observed over time; for both cytokines, the ﬁrst trimester level was signiﬁcantly less than
American Journal of Perinatology Reports
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Table 2 Repeated-measures models for each cytokine with main effects of length-of-pregnancy status and trimester
CVF

Serum

n

F

p

n

F

p

226

0.2

0.64

243

3.7

0.054

4.6

0.010

1.9

0.15

11.4

<0.001

4.9

0.028

IL-1α
Length-of-pregnancy
Trimester
IL-1β
Length-of-pregnancy

223

240

Trimester

4.6

0.011

<0.1

0.99

Length-of-pregnancy  trimester

3.0

0.049

–

–

7.3

0.007

9.1

0.0028

0.6

0.53

0.4

0.69

4.2

0.042

1.0

0.32

3.1

0.046

3.0

0.049

20.8

<0.001

0.5

0.49

16.4

<0.001

1.8

0.16

7.2

0.0079

1.2

0.27

2.2

0.11

4.4

0.013

26.5

<0.001

43.1

<0.001

10.1

<0.001

9.1

<0.001

0.2

0.62

5.4

0.022

3.7

0.027

2.9

0.056

IL-6
Length-of-pregnancy

224

Trimester

242

IL-8
Length-of-pregnancy

227

Trimester

243

IL-10
Length-of-pregnancy

225

Trimester

239

CRP
Length-of-pregnancy

227

Trimester

234

TNF-α
Length-of-pregnancy

226

Trimester

240

MMP-8
Length-of-pregnancy

158

Trimester

180

Abbreviations: CRP, C-reactive protein; CVF, cervicovaginal ﬂuid; IL, interleukin; MMP, matrix metalloproteinase; TNF, tumor necrosis factor.
Note: Models adjusted for age, race/ethnicity, education, and ﬁrst trimester smoking status; only those with complete data on all covariates, and
those with cytokine data at any trimester, are included in the model.

Fig. 1 Mean (95% conﬁdence interval [CI]) untransformed CVF levels among women during pregnancy signiﬁcantly varying by length of
pregnancy. (a) IL-6, (b) IL-10, (c) CRP, (d) TNF-α.
American Journal of Perinatology Reports
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Fig. 2 Mean (95% CI) untransformed CVF IL-1β levels among women during pregnancy by preterm birth status at each trimester. Repeatedmeasures models showed signiﬁcant elevated levels among women who delivered preterm in both second (t ¼ 2.2; p ¼ 0.029) and third
trimesters (t ¼ 3.9; p < 0.001).

Fig. 3 Mean (95% CI) untransformed CVF levels among women signiﬁcantly varying during pregnancy by trimester. (a) IL-1α, (b) IL-8, (c) IL-10,
(d) TNF-α, (e) MMP-8.

both second and third, while for TNF-α the second trimester
level was also signiﬁcantly less than that of the third
trimester.

Discussion
For each CVF cytokine that differed by length-of-pregnancy
status, values were higher for preterm than full-term births,
averaged over trimester. This included signiﬁcant differences
in IL-6, IL-8, IL-10, TNF-α, and CRP between women who
delivered preterm versus full-term. This is consistent with
previous research ﬁndings on higher levels of CVF IL-8
associated with gestational age,12 spontaneous preterm
birth,13 and, among women with preterm labor and without
PPROM, delivery within 7 days.14 One study found no asso-

ciation between CVF IL-8 and cervical shortening at 20 or 24
weeks’ gestation;15 given the difference between this result
and our present ﬁndings, changes in IL-8 may be better
detected later in pregnancy, or may be associated with other
symptoms of preterm birth.
A strength of this study is that it is one of the ﬁrst to
examine cytokines in both serum and CVF across all three
trimesters of pregnancy. Also, studies examining preterm
birth often do not validate smoking status, often due to
feasibility or cost. Our study is also among the ﬁrst to use
biochemical validation of smoking status (via urine cotinine)
at each time point.
Several studies have found associations between CVF IL-6
and preterm birth. Higher levels of CVF IL-6 were associated
with delivery within 7 days among women with preterm
American Journal of Perinatology Reports
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Fig. 4 Mean (95% CI) untransformed serum levels among women during pregnancy signiﬁcantly varying by length of pregnancy. (a) IL-6,
(b) TNF-α, (c) MMP-8.

Fig. 5 Mean (95% CI) untransformed serum levels among women during pregnancy signiﬁcantly varying by trimester. (a) IL-8, (b) CRP, (c) TNF-α.

labor.14 In a sample of women tested at hospital admission,
CVF IL-6 was signiﬁcantly higher among women with PPROM
compared with controls, matched for gestational age.16 Like
our investigation, Reyna-Vallasmil et al found CVF IL-6,
measured in the second trimester, was signiﬁcantly higher
among women who later delivered preterm.17 In contrast, a
study by Cox et al with full-term pregnancies did not
demonstrate CVF IL-6 to be signiﬁcantly different between
women either in labor or not in labor.18
In congruence with our ﬁndings, CVF CRP was found to be
associated with microbial invasion of the amniotic cavity
(MIAC) in women with PPROM.19 Our ﬁndings, however, are
in contrast to those of Cobo et al, who found that CVF TNF-α
was undetectable in over 50% of a sample of women with
PPROM,19 as well as Seong et al, who found no association
between TNF-α and cervical shortening at 20 or 24 weeks’
gestation.15
Dutt et al found that CVF IL-10 was signiﬁcantly higher in
non-Caucasian than Caucasian women in both the second
and third trimesters of pregnancy.20 In fact, the median CVF
IL-10 levels among Caucasian women were below the level of
detection in each trimester, so it is notable that IL-10 was
associated with preterm birth in the present study, conducted with a mostly Caucasian (75.8%) sample. It is possible
that Dutt et al’s non-Caucasian sample and the present
study’s sample share salient similarities (e.g., lower-thanaverage household income, cumulative life stress) which
contribute to higher levels of CVF IL-10 and an association
with preterm birth.
The ﬁndings of elevated CVF cytokines, averaged over
trimester, among women who delivered preterm are in contrast with serum cytokine values: for these, nearly all of the
cytokines that exhibited a signiﬁcant difference for the term/
preterm comparison were lower for preterm births compared
American Journal of Perinatology Reports
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with term. This is true for IL-1β, IL-6, and TNF-α, when
averaged over trimester. This ﬁnding is very intriguing and a
value of the study. Our ﬁnding suggests that expression of the
inﬂammatory response is not consistent across all biologic
pools and, for pregnancy, appears concentrated on the local
cervical reaction when a pathophysiology potentially responsible for preterm birth is present. Only MMP-8 measured in
serum was higher for preterm than term deliveries. A composite proﬁle of inﬂammatory mediators may help improve the
prediction for preterm birth and the extent of the response to
an ongoing pathophysiology.
Others have found differences in CVF versus serum cytokine levels relative to preterm birth. Yavari Kia et al found
signiﬁcant differences and no correlation between serum
and CVF levels of IL-6 among women with preterm uterine
contractions.21 Since elevated inﬂammatory biomarkers are
thought to indicate higher risk of earlier birth, our ﬁndings
concur with Yavari Kia et al’s conclusion that testing for
serum cytokine levels would be not be clinically useful for
predicting preterm birth.
Gillespie et al found that IL-1β, IL-6, and TNF-α increased
from early to late pregnancy among a sample of women with
a mean gestational age at delivery of over 39 weeks (SD
¼ 1.0–1.1).22 Other studies, including one by Ferguson et al,
have found a similar trajectory as Gillespie et al for IL-6
(increasing from 20 weeks’ gestation to the end of pregnancy).23,24 However, mean values of serum IL-6 were signiﬁcantly higher for women who delivered preterm than
full-term in Ferguson et al’s sample, and there was no
signiﬁcant difference in serum IL-1β or TNF-α between
length-of-pregnancy groups. Our ﬁnding that serum IL-1β,
IL-6, and TNF-α levels were lower, when averaged over
trimester, for women with preterm births than full-term
births may suggest that the women who delivered preterm
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had not yet reached peak levels of these serum cytokines.
Alternatively, it is possible that the women who delivered
preterm may have a different pattern or trajectory of serum
cytokines than Gillespie et al’s sample of women, most of
whom delivered full-term, and Ferguson et al’s sample,
which had a higher proportion of nonsmokers.
There was a signiﬁcant interaction between preterm
status and trimester for IL-1β only. Women who delivered
preterm had signiﬁcantly higher CVF IL-1β values at second
and third trimester, compared with full-term births, but
there was no difference between the preterm status groups
during ﬁrst trimester in CVF IL-1β. One study found associations between CVF IL-1β and gestational age, active labor,
and, among women with full-term pregnancies, cervical
dilation.12 Other studies, however, found IL-1β to be not
associated with cervical length in the second trimester,15 nor
to be an independent predictor of MIAC.19 While CVF IL-1β
may not be associated with speciﬁc symptoms of preterm
birth (cervical shortening, MIAC), our ﬁndings indicate a
unique difference in CVF IL-1β between women with preterm and full-term deliveries.
For the main effect of trimester (averaging term/preterm
groups together), there tended to be an increase in level
over time for CVF cytokine values. This is true for and
consistent with other studies on IL-1α, IL-8,12 IL-10, and
MMP-8. CVF IL-10 also increased over time, which is similar
to Dutt et al’s ﬁnding for non-Caucasian, but not for
Caucasian, women.20 However, CVF TNF-α had the opposite
relationship: a decrease over time. This is potentially congruent with earlier ﬁndings that CVF TNF-α was undetectable for over 50% of a sample of women with PPROM before
34 weeks’ gestation.19 Taken together, it is possible that
TNF-α levels decreased during pregnancy to the point of
going below the threshold of detection for pregnancies
further complicated by PPROM.
The serum values of IL-8, TNF-α, and CRP had similar
patterns over time, with a tendency toward increase in level
over trimester. Earlier studies have found similar trajectories
for serum TNF-α,22,23 but Ferguson et al found a quadratic
trajectory for serum CRP: increasing until 20 weeks’ gestation, and then decreasing until delivery.23 Our ﬁndings also
differ from another study’s result of no signiﬁcant difference
in serum IL-8 from ﬁrst to third trimester, though this was
found in a much smaller sample (n ¼ 26).24

Limitations

values were higher for preterm than term births, averaged
over trimester. Numerous cytokine proﬁles varied across
trimesters in women delivering term versus preterm in
both CVF and serum. These differences indicate the need
for further research on connections between maternal cytokine proﬁles and birth outcomes.
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